MRD blood test for stage III colorectal cancer
Part of Cancer, Digestive system clinical trials.
This trial is for people with stage III colorectal cancer who haven't had treatment yet. It tests a blood test to find tiny bits of cancer DNA (MRD) after surgery, which may help doctors know if more treatment is needed.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 or older
- You have stage III colorectal cancer that can be removed with surgery
- You have not had any cancer treatment yet (like chemo or radiation)
- You are able to do your daily activities with little or no help (ECOG score 0 or 1)
- You have no history of other cancers
- You are not pregnant or breastfeeding
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study uses a blood test to check for tumor DNA after surgery, which may help doctors decide if you need additional chemotherapy. It is for people with stage 3 colorectal cancer that is removed by surgery.
This study looks at how well targeted therapies work for people with colorectal cancer who have minimal residual disease (MRD, tiny amounts of cancer left after treatment) detected by a blood test. It is for people who have a specific genetic change (biomarker) in their tumor and have not been treated with the targeted therapy for that biomarker before.
This trial uses a blood test (liquid biopsy) to look for tiny bits of cancer DNA remaining after surgery. It aims to see if this test can help guide follow-up and treatment decisions for people with colorectal cancer.
This study uses a simple blood test (liquid biopsy) to look for tiny bits of tumor DNA remaining after colorectal cancer surgery. It aims to see if the test can help predict whether the cancer will come back, especially in people with stage III cancer who will receive chemotherapy.
This study tests if a simple blood test can detect early signs of colorectal cancer coming back after surgery to remove cancer spread in the abdomen. It may help patients avoid unnecessary treatments and catch recurrence sooner.
This Phase 3 trial compares two chemotherapy regimens after surgery in people whose MRD test is positive, meaning tiny remaining cancer cells may still be present. It aims to see which treatment helps prevent cancer coming back more effectively.
Hear when a new Colorectal cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.